Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

CRISPR/Cas technology originated from the immune mechanism of archaea and bacteria and was awarded the Nobel Prize in Chemistry in 2020 for its success in gene editing. Molecular diagnostics is highly valued globally for its development as a new generation of diagnostic technology. An increasing num...

Full description

Bibliographic Details
Main Authors: Kun Chen, Ziyi Shen, Guanzhen Wang, Wei Gu, Shengchao Zhao, Zihan Lin, Wei Liu, Yi Cai, Gohar Mushtaq, Jia Jia, Chunpeng (Craig) Wan, Tingdong Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
molecular diagnostics
CRISPR/Cas
biosensor
non-nucleic-acid analytes
nucleic acid detection
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2022.986233/full

Internet

https://www.frontiersin.org/articles/10.3389/fbioe.2022.986233/full

Similar Items